Medical Communications

Showing 15 posts of 6402 posts found.

moderna_norwood_plant

Moderna publishes antibody persistence data of COVID-19 vaccine

April 9, 2021 Medical Communications

Moderna have published antibody persistence data out to six months following the second dose of its COVID-19 vaccine (mRNA-1273) in …
lilly_entrance_web

Lily and Incyte Phase III COVID-19 study fails to meet primary endpoint

April 9, 2021 Medical Communications COVID-19, Eli Lily

Results from Eli Lily and Incyte’s Phase III study, COV-BARRIER, evaluating baricitinib in the treatment of hospitalised COVID-19 patients did …
abbottweb

Abbott receives CE mark approval for TriClip device

April 9, 2021 Medical Communications

Abbott have received CE Mark approval for its next-generation TriClip Transcatheter Tricuspid Valve Repair System, the first-of-its-kind tricuspid heart valve …

Intravac appoints Nathalie Laarakker as CFO

April 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Intravac have announced the appointment of Nathalie Laarakker as its new CFO and member of the company’s executive management team. …

Smithers promotes Nikki Lucas to Principal Project Manager

April 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Nikki Lucas has been appointed Principal Project Manager within Smithers’ Medical Device Physical Testing team. Lucas has over a decade …

New CEO appointed at Nordic Nanovector

April 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Nordic Nanovector have appointed Peter Braun as their new Chief Executive Officer. Braun is an experienced and entrepreneurial pharmaceutical leader, …
chas_taylor

Ceryx Medical announce new chairman Chas Taylor

April 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Cardiovascular technology company Ceryx Medical have appointed Chas Taylor as their new chairman. The appointment comes at an interesting time …
Top 10 news roundup

Pharmafile.com’s top 10 news stories of the week

March 26, 2021 Medical Communications AstraZeneca vaccine, COVID-19, covid 19 news, covid-19 news, news, news roundup, starpharma

In the last week, a number of new developments have made the news; for COVID-19, Starpharma will begin to sell …

FDA approve Astellas’s Myrbetriq treatment for bladder dysfunction

March 26, 2021 Medical Communications Astellas Pharma, FDA, Ida approval

The FDA have approved a new indication for Astellas Pharma’s Myrbetriq and Myrbetriq Granules to treat neurogenic detrusor overactivity (NDO), …
credit_-_daniel_leal-olivas-afp

Astellas Pharma and Seagen cancer treatment gets MAA acceptance from EMA

March 26, 2021 Medical Communications EMA, oncology

Astellas Pharma and Seagen Inc. have announced that the EMA has accepted their marketing authorisation application (MAA) for enfortumab vedotin, …

Novavax delays 100 million vaccines to the EU

March 26, 2021 Medical Communications COVID-19, EU, Vaccine

Novavax is delaying the signing of a contract to supply COVID-19 vaccines to the EU, as the company warned it …
Pfizer's New York headquarters

Pfizer begins COVID-19 vaccine testing on young children

March 26, 2021 Medical Communications COVID-19, Pfizer, Vaccine

Pfizer have begun testing its COVID-19 vaccine on children under the age of 12, with the trials’ first participants, a …
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

March 19, 2021 Medical Communications COVID, COVID-19, covid 19 news, covid-19 news, news, news roundup, pharma news

In the last week, a number of new developments have made the news; for COVID-19, the Oxford-AstraZeneca vaccine has been …

RDIF & Stelis Biopharma to supply 200 million doses of the Sputnik V vaccine

March 19, 2021 Medical Communications COVID-19, Russia, Vaccine

The Russian Direct Investment Fund (RDIF) and Stelis Biopharma have today announced a partnership which aims to produce and supply …

NICE recommends new triple therapy for multiple myeloma patients

March 19, 2021 Medical Communications NHS England, NICE, oncology

A new second line triple therapy is to be offered to NHS patients in England with multiple myeloma, following a …
The Gateway to Local Adoption Series

Latest content